(Q54303001)

27 May 2018

title

DNA methylation of circulating DNA: a marker for monitoring efficacy of neoadjuvant chemotherapy in breast cancer patients. (English)

1 reference

27 May 2018

0 references

1 reference

Gayatri Sharma

1

1 reference

27 May 2018

Sameer Mirza

2

1 reference

27 May 2018

Rajinder Parshad

3

1 reference

27 May 2018

Siddartha Datta Gupta

4

1 reference

27 May 2018

Ranju Ralhan

5

1 reference

27 May 2018

publication date

29 June 2012

1 reference

27 May 2018

published in

Tumor Biology

1 reference

27 May 2018

volume

33

1 reference

27 May 2018

issue

6

1 reference

27 May 2018

page(s)

1837-1843

1 reference

27 May 2018

https://scigraph.springernature.com/pub.10.1007/s13277-012-0443-y

exact match

0 references

cites work

Randomized trial comparing neo-adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0-2 M0).

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

Neoadjuvant endocrine therapy in primary breast cancer: indications and use as a research tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

Update on locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

Neoadjuvant systemic therapy for breast cancer: an overview and review of recent clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

CA 15-3 is predictive of response and disease recurrence following treatment in locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

Predictive value of serum anti-p53 antibodies, carcino-embryonic antigen, carbohydrate antigen 15-3, estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in taxane-based and anthracycline-based neoadjuvant chemothera

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

Epigenetic regulation of WTH3 in primary and cultured drug-resistant breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

Epigenetic mechanisms of drug resistance: drug-induced DNA hypermethylation and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

Mechanisms of cancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

Introduction to resistance to anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

Cancer epigenetics reaches mainstream oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

Detection of RASSF1A and RARbeta hypermethylation in serum DNA from breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

The role of BRCA1 in the cellular response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

BRCA1 at the crossroad of multiple cellular pathways: approaches for therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

New role for nuclear hormone receptors and coactivators in regulation of BRCA1-mediated DNA repair in breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

BRCA1 gene in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

The basal phenotype of BRCA1-related breast cancer: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

A clinically relevant gene signature in triple negative and basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

Serum DNA methylation for monitoring response to neoadjuvant chemotherapy in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0443-Y

Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer

21 January 2018

1 reference

12 December 2020

SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers

1 reference

12 December 2020

Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients.

1 reference

12 December 2020

Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

12 December 2020

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer

1 reference

12 December 2020

Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR

1 reference

12 December 2020

Cellular mechanisms of multidrug resistance of tumor cells.

1 reference

12 December 2020

Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk

1 reference

12 December 2020

Prognostic DNA methylation marker in serum of cancer patients

1 reference

12 December 2020

DNA methylation in serum of breast cancer patients: an independent prognostic marker

1 reference

12 December 2020

1 reference

12 December 2020

Drug-induced DNA hypermethylation and drug resistance in human tumors.

1 reference

12 December 2020

10.1007/S13277-012-0443-Y

Identifiers

DOI

1 reference

27 May 2018

PubMed ID

22744714

1 reference

27 May 2018